CEO sold ~$192K of UTHR shares in the open market

Past results only. Not a forecast.

Record ID

0001106578-26-000009

Filed / recorded

Mar 12, 2026, 3:31 AM UTC

Added to OQRO

Oct 6, 2026, 9:34 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

UNITED THERAPEUTICS Corp

Issuer CIK

1082554

Ticker

UTHR

Reporting person

Martine A Rothblatt

Relationship

Director, Officer

Officer title

Chairperson & CEO

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Mar 11, 2026

Transaction code

S

Shares / units

360

Price per share

$532.13

Acquired / disposed

Disposed (D)

Shares owned after

9,270

Ownership form

Direct

Amendment

No

1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.
2. This transaction was executed in multiple trades at prices ranging from $531.90 to $532.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.